1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > US Nuclear Medicine and PET Imaging Systems Market

US Nuclear Medicine and PET Imaging Systems Market

  • May 2014
  • -
  • Frost & Sullivan
  • -
  • 123 pages

This research service pertains to the US market for nuclear medicine and positron emission tomography (PET) imaging systems. Providing thorough market sizing and forecast of market revenue, unit shipments, procedure volumes, average pricing, and installed base, the study analyzes market trends, drivers and restraints, along with the reimbursement and the competitive environments at the total level and within each segment. Planar scinigraphy, stand-alone SPECT, and hybrid SPECT-CT are included in the nuclear medicine segment; whereas stand-alone PET, hybrid PET-CT, and hybrid PET-MR are the sub-segments considered in the PET segment. The base year of the study is 2013 and the forecast period extends 7 years through 2020.


Key Findings

The US molecular imaging equipment market is comprised of two fairly mature market
segments: Nuclear medicine, mainly single-photon emission computed tomography
(SPECT), and positron emission tomography (PET) systems.

The demand for these two imaging modalities continues to arise mostly from traditional
molecular imaging procedures, such as technetium-based SPECT and fludeoxyglucose
(FDG)-based PET.

Despite promising advances in new clinical areas, each modality continues to find most
market opportunity within its respective stronghold—cardiology for SPECT and oncology
for PET.

Each modality is evolving only gradually beyond its traditional clinical area of application,
including PET imaging growing into cardiac and neurology imaging, and nuclear medicine
growing into new diagnostic and therapeutic applications.

While PET slowly gains acceptance among cardiologists and SPECT gains some traction
with organs other than the heart through the use of new radiopharmaceuticals, the impact
on market demand for new systems remains fairly marginal.
The stream of market revenues continues to derive mostly from system replacements
drawing from an aging installed base, particularly of legacy SPECT cameras and
equipment, yielding low single-digit revenue growth rates in both segments.

Some notable recent technology and radiopharmaceutical advances are serving the case
for some of these system replacements, but this is partly offset by the more intense inter-modality competition that advances are creating between PET and SPECT.

Despite continuing pressure on reimbursement levels, which was reinvigorated with the
Deficit Reduction Act of 2006 and continued ever since, the most recent revisions by the
Center of Medicare and Medicaid Services (CMS) came with a slightly more positive note.

Indeed, 2013 fee schedule updates provided of an increase in reimbursement levels of
between x and x% for both SPECT and PET across various imaging procedures.

However, a three-year period of radioisotope shortages between 2008 to 2010 followed a
slow restoration of industry supply of Molybdenum radiopharmaceuticals during 2012, the
last few years served to exemplify the vulnerability of the molecular imaging market in
general to unforeseen external, accidental or ancillary factors.

Table Of Contents

US Nuclear Medicine and PET Imaging Systems Market
Table of Contents


Executive Summary 8
Market Overview and Segmentation 17
Total Nuclear Medicine and PET Imaging Systems Market -
External Challenges: Drivers and Restraints 25
Forecasts and Trends 42
Market Share and Competitive Analysis 55
Procedure Volumes and Reimbursement Landscape 62
Nuclear Medicine Imaging Systems Segment Breakdown 72
PET Imaging Equipment Segment Breakdown 94
The Last Word 118
Appendix 121

List of Exhibits
Total Nuclear Medicine and PET Imaging Systems Market: Market Engineering Measurements, United States, 2013 13
Total Nuclear Medicine and PET Imaging Systems Market: Market Segmentation, United States, 2013 20
Total Nuclear Medicine and PET Imaging Systems Market: Percent Sales Breakdown, United States, 2013 21
Total Nuclear Medicine and PET Imaging Systems Market: Revenue Breakdown by Geographic Region, Global, 2012 22
Total Nuclear Medicine and PET Imaging Systems Market: Market Outlook, United States, 2013 and 2023 23
Total Nuclear Medicine and PET Imaging Systems Market: Impact of Top 6 Trends, United States, 2013 24
Total Nuclear Medicine and PET Imaging Systems Market: Key Market Drivers and Restraints, United States, 2014-2020 26
Total Nuclear Medicine and PET Imaging Systems Market: Key Market Drivers, United States, 2014-2020 27
Total Nuclear Medicine and PET Imaging Systems Market: Key Market Restraints, United States, 2014-2020 34
Total Nuclear Medicine and PET Imaging Systems Market: Market Drivers and Restraints, United States 2014-2020 41
Total Nuclear Medicine and PET Imaging Systems Market: SPECT and PET Radiopharmacy Facility Landscape, United States, 2012 45
Total Nuclear Medicine and PET Imaging Systems Market: Market Engineering Measurements, United States, 2012 46
Total Nuclear Medicine and PET Imaging Systems Market: Revenue Forecast, United States, 2010-2020 50
Total Nuclear Medicine and PET Imaging Systems Market: Revenue Forecast by Segment, United States, 2010-2020 53
Nuclear Medicine Imaging Systems Market: Select Industry Participants and Main Product Lines, United States, 2013 56
PET Imaging Systems Market: Select Industry Participants and their Main Product Lines, United States, 2013 57
Total Nuclear Medicine and PET Imaging Systems Market: Percent of Sales, United States, 2013 58
Total Nuclear Medicine and PET Imaging Systems Market: Company Market Share Analysis of Top 3 Participants, United States, 2013 59
Total Nuclear Medicine and PET Imaging Systems Market: Competitive Structure, United States, 2013 60
Nuclear Medicine Imaging Systems Segment: Procedure Volume Forecast, United States, 2010-2020 63
PET Imaging Systems Segment: Procedure Volume Forecast, United States, 2010-2020 65
Total Nuclear Medicine and PET Imaging Systems Market: Procedure Reimbursement, United States, 2013 69
Nuclear Medicine Imaging Systems Market: Key Technology and Product Trends, United States, 2013 75
Nuclear Medicine Imaging Systems Segment: Revenue Forecast, United States, 2010-2020 80
Nuclear Medicine Imaging Systems Segment: Revenue Forecast by Sub-Segment, United States, 2010-2020 82
Nuclear Medicine Imaging Systems Segment: Unit Shipments Forecast, United States, 2010-2020 84
Nuclear Medicine Imaging Systems Segment: Unit Shipment Forecast by Product Segment, United States, 2010-2020 86
Nuclear Medicine Imaging Systems Segment: Pricing Trends and Forecast, United States, 2010-2020 88
Nuclear Medicine Imaging Systems Segment: Installed Base Forecast, United States, 2010-2020 90
Nuclear Medicine Imaging Systems Segment: Percent of Sales, United States, 2013 92
Nuclear Medicine Imaging Systems Segment: Company Market Share Analysis of Top 3 Participants, United States, 2013 93
PET Imaging Systems Segment: Key Technology and Product Trends, United States, 2013 97
PET Imaging Systems Segment: Revenue Forecast, United States, 2010-2020 104
PET Imaging Systems Segment: Revenue Forecast by Segment, United States, 2010-2020 106
PET Imaging Systems Segment: Unit Shipments Forecast, United States, 2010-2020 108
PET Imaging Systems Segment: Unit Shipment Forecast by Product Segment, United States, 2010-2020 110
PET Imaging Systems Segment: Pricing Trends and Forecast, United States, 2010-2020 112
PET Imaging Systems Segment: Installed Base Forecast, United States, 2010-2020 114
PET Imaging Systems Segment: Percent of Sales, United States, 2013 116
PET Imaging Systems Segment: Company Market Share Analysis of Top 3 Participants, United States, 2013 117

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the ...

Global Nuclear Medicine Market

Global Nuclear Medicine Market

  • $ 4250
  • Industry report
  • October 2016
  • by Mordor Intelligence LLP

The global nuclear medicines market is expected to reach USD 17,600 million by the end of 2020, growing at a CAGR of around 12.29% from 2015 to 2020. Nuclear medicine utilizes the radioisotope for application ...

Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2016 Market Research Report

Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese European Nuclear Medicine / Radiopharmaceuticals Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global European ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.